Chetan Lathia Selected Research

Chetan Lathia Research Topics

Disease

12	Neoplasms (Cancer) 07/2011 - 08/2002
3	Melanoma (Melanoma, Malignant) 11/2011 - 06/2007
3	Kidney Neoplasms (Kidney Cancer) 10/2010 - 06/2007
3	Fatigue 08/2009 - 01/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2012 - 05/2007
2	Hypertension (High Blood Pressure) 11/2011 - 08/2005
2	Hepatocellular Carcinoma (Hepatoma) 03/2011 - 09/2006
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2010 - 07/2009
2	Exanthema (Rash) 08/2009 - 08/2005
2	Diarrhea 05/2007 - 09/2006
1	Colorectal Neoplasms (Colorectal Cancer) 02/2015
1	Adenocarcinoma 02/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2011
1	Hyperbilirubinemia 03/2011
1	Fibrosis (Cirrhosis) 03/2011
1	Disease Progression 03/2011
1	Breast Neoplasms (Breast Cancer) 08/2009
1	Ovarian Neoplasms (Ovarian Cancer) 01/2006
1	Neutropenia 01/2006
1	Thrombocytopenia (Thrombopenia) 01/2006
1	Lymphopenia (Lymphocytopenia) 01/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2006
1	Agranulocytosis (Granulocytopenia) 10/2005

Drug/Important Bio-Agent (IBA)

14	Sorafenib (BAY 43-9006)FDA Link 01/2012 - 08/2005
6	Biomarkers (Surrogate Marker)IBA 02/2015 - 08/2005
4	Pharmaceutical PreparationsIBA 03/2011 - 08/2005
3	Phosphotransferases (Kinase)IBA 02/2015 - 05/2006
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2010 - 08/2005
2	Blood Proteins (Serum Proteins)IBA 01/2012 - 10/2010
2	Lipase (Acid Lipase)FDA Link 11/2011 - 01/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2010 - 07/2009
2	raf KinasesIBA 09/2006 - 08/2005
1	Cell-Free Nucleic AcidsIBA 02/2015
1	regorafenibIBA 02/2015
1	Cytochrome P-450 CYP2C19IBA 11/2011
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2011
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 11/2011
1	IsoenzymesIBA 11/2011
1	Midazolam (Versed)FDA LinkGeneric 11/2011
1	Omeprazole (Prilosec)FDA LinkGeneric 11/2011
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 11/2011
1	Cytochrome P-450 CYP3AIBA 11/2011
1	Dacarbazine (DIC)FDA LinkGeneric 07/2011
1	Growth Factor ReceptorsIBA 07/2011
1	Tissue Inhibitor of Metalloproteinase-1IBA 10/2010
1	Carbonic Anhydrase IXIBA 10/2010
1	Carboplatin (JM8)FDA LinkGeneric 08/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2008
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2007
1	Interleukin-2 (IL2)IBA 06/2007
1	aldesleukin (Proleukin)FDA Link 06/2007
1	Gefitinib (Iressa)FDA Link 05/2007
1	Alanine Transaminase (SGPT)IBA 05/2007
1	tyrosine receptor (receptor, tyrosine)IBA 09/2006
1	thiamine triphosphorate (TTP)IBA 09/2006
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2006
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2006
1	Tyrosine (L-Tyrosine)FDA Link 05/2006
1	Gemcitabine FDA Link 01/2006
1	GlycoconjugatesIBA 10/2005
1	20- O- (Nalpha- (4- (3- O- methylfucopyranosyloxy)phenylaminothiocarbonyl)histidylvalyl)camptothecinIBA 10/2005
1	LactonesIBA 10/2005
1	CamptothecinIBA 10/2005
1	Mitogen-Activated Protein KinasesIBA 08/2005
1	Pentostatin (Nipent)FDA LinkGeneric 08/2002

Therapy/Procedure

2	Therapeutics 02/2015 - 03/2011
1	Drug Therapy (Chemotherapy) 08/2009